NYSE: GMED - Globus Medical

Yield per half year: +22.16%
Sector: Healthcare

Current price
74.05 $
Average price
76.31 $ +3.05%

Average analyst price
71 $ -4.12%
Price based on EPS
11.54 $ -84.41%
Price according to DCF model (FCF)
51.26 $ -30.78%
Discount price Net Income
29.82 $ -59.73%
2/10

Average analyst price

Fair price = 71 $
Current price = 74.05 $ (difference = -4.12%)

Idea Price forecast Changes Expiration date Analyst
More details 71 $ -3.05 $ (-4.12%) 11.01.2025 Morgan Stanley

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 11.54 $
Current price = 74.05 $ (difference = -84.41%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 217.9 $
Current price = 74.05 $ (difference = +194.26%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 51.26 $
Current price = 74.05 $ (difference = -30.78%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription